Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sidley Chemical is a specialized manufacturer and supplier of cellulose ethers and related chemical products, primarily serving the pharmaceutical, construction, and food industries. The company produces a comprehensive range of pharmaceutical-grade excipients, including Hydroxypropyl Methylcellulose (HPMC), Hydroxyethyl Cellulose (HEC), and Ethyl Cellulose (EC), which are critical for drug delivery systems such as controlled-release tablets and film coatings. Headquartered in China, Sidley Chemical operates advanced production facilities that comply with international quality standards to ensure the purity and consistency of its products. The company's portfolio also includes Sodium Carboxymethyl Cellulose (CMC) and Calcium Formate, supporting diverse applications in thickening, binding, and stabilization. Sidley Chemical is a key player in the global excipient market, exporting its products to numerous countries across Europe, Asia, and the Americas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sidley Chemical.